Private Banking|Professional Solutions|Investment Management|Investment Banking|About us
Login
Van Lanschot Kempen Logo
  • Solutions
  • Sectors
  • Careers
Van Lanschot Kempen Logo
Login

Transactions 2021

Dec 2021
union investment
Sole Financial Adviser
Undisclosed
Real Estate Acquisition Financing
Dec 2021
feac
Joint Bookrunner
USD 127 million
IPO of Forbion European Acquisition Corp
Nov 2021
merus
Lead manager
USD 127 million
US Public Offering
Nov 2021
infestos
Financial Adviser
€ 178 million
Public offer for
Nov 2021
io biotech
Lead Co-Manager
USD 100 million
Initial Public Offering on Nasdaq
Nov 2021
maat
Joint Global Coordinator
& Joint Bookrunner
€ 31.5 million
Initial Public Offering
Sep 2021
tritax eurobox
Joint Global Coordinator
& Joint Bookrunner
€ 250 million
Placing
Sep 2021
aquila
Joint Bookrunner
€ 90 million
Capital Increase
Sep 2021
ascendis
Co-Manager
USD 460 million
US Public Offering
Aug 2021
spryng
Sole Financial Adviser
Sale to Commify
Aug 2021
gilde
Sole Financial Adviser
€ 80 million
Public takeover of DPA Professionals
Aug 2021
calliditas
Joint Bookrunner
SEK 324 million
Accelerated Bookbuild Offering
Jul 2021
brane
Joint Global Coordinator
& Joint Bookrunner
SEK 380 million
Accelerated Bookbuild Offering
Jun 2021
ticketswap
Financial adviser
€ 10 million
Capital increase
Jun 2021
aedifica
Joint Global Coordinator
& Joint Bookrunner
€ 286 million
Accelerated Bookbuild Offering
Jun 2021
immunicum
Joint Global Coordinator & Joint Bookrunner
SEK 141.2 million
Accelerated Bookbuild Offering
Jun 2021
molecular partners
Lead Manager
USD 63.8 million
Initial Public Offering on Nasdaq
Jun 2021
peach property group
Sole Global Coordinator
CHF 180 million
Mandatory Convertible Bond Offering
Jun 2021
transgene
Joint Global Coordinator
€ 34.1 million
Accelerated Bookbuild Offering
Jun 2021
q linea
Joint Bookrunner
SEK 301 million
Accelerated Bookbuild Offering
Apr 2021
catena
Joint Bookrunner
SEK 1.08 billion
Accelerated Bookbuild Offering
Apr 2021
compleo
Joint Global Coordinator & Joint Bookrunner
€ 28.3 million
Accelerated Bookbuild Offering
Apr 2021
achilles
Co-Manager
USD 176 million
Initial Public Offering on Nasdaq
Mar 2021
tritax eurobox
Joint Global Coordinator
Joint Bookrunner
€ 230 million
Capital increase
Mar 2021
ebac by lsp logo
Joint Bookrunner
USD 120 million
Initial Public Offering on Nasdaq
Mar 2021
gensight
Joint Bookrunner
€ 30 million
Accelerated Bookbuild Offering
Mar 2021
ctp
Joint Bookrunner
€ 948 million
Initial Public Offering
Mar 2021
oncopeptides
Joint Bookrunner
SEK 1.11 billion
Accelerated Bookbuild Offering
Mar 2021
lava
Lead Manager
USD 101 million
Initial Public Offering on Nasdaq
Feb 2021
sequana medical
Joint Global Coordinator & Joint Bookrunner
€ 22.5 million
Accelerated Bookbuild Offering
Feb 2021
autolus
Co-Manager
USD 115 million
US Public Offering
Feb 2021
esg
Co-Bookrunner
€ 250 million
Initial Public Offering
Feb 2021
y-mabs
Lead Co-Manager
USD 115 million
US Public Offering
Feb 2021
BioInvent
BioInvent
SEK 962 million
Private Placement
Feb 2021
pharvaris
Co-Manager
USD 165 million
Initial Public Offering
Feb 2021
wdp
Joint Global Coordinator & Joint Bookrunner
€ 200 million
Accelerated Bookbuild Offering
Jan 2021
vastned
Financial Adviser
€ 40 million
Green Revolving Credit Facility
Jan 2021
curevac
Bookrunner
USD 450 million
US Public Offering
Jan 2021
merus
Lead Manager
USD 120 million
US Public Offering
Jan 2021
somerset capital partners
Lead Arranger
€ 75 million
Debt financing

Fully focused on your future

Private Banking

  • Offices
  • Entrepreneurs
  • Healthcare
  • Executives
  • Business professionals
  • Wealth management
  • Conditions
  • Private Banking - Belgium
  • Private Banking - Switzerland

Professional Solutions

Investment Management

Investment Banking

© Van Lanschot Kempen NV 2023
About us
Security and fraud awareness
Privacy & cookies
Disclaimer